United KingdomScientists have developed an advanced optical imaging technique called optical metabolic imaging (OMI) that allows for the non-invasive measurement of metabolic activity in individual immune cells within a complex blood sample. This method, which uses naturally occurring metabolic cofactors and two-photon microscopy, provides detailed insights into cell function without altering the cells or requiring fluorescent labels. The research, led by Melissa Skala at the Morgridge Institute for Research and the University of Wisconsin–Madison, highlights the potential of OMI to improve understanding of diseases like cancer and autoimmune disorders, as well as enhance cell therapies such as CAR T-cell treatments. The study was published in Biophotonics Discovery.
Bias read (Center): The article presents scientific research without political implications. It focuses on medical advancements and technological innovations in immunology, which do not involve politically charged topics such as governance, elections, or social policies. The framing remains neutral, focusing on factual
